The Prevalence and Risk Factors for Abnormal Liver Enzymes in HIV-Positive Patients without Hepatitis B or C Coinfections

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Digestive Diseases and Sciences

• Publication date

  2008-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s10620-007-9999-6PMID 17939038PMCID PMC3836444
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Severe Liver Disease Associated With Prolonged Exposure to Antiretroviral Drugs

  2006influential reference
• Liver biopsy findings for HIV-infected patients with chronic hepatitis C and persistently normal levels of alanine aminotransferase.

  2006cited by this paper
• Drug-Induced Liver Injury in HIV Patients.

  2006cited by this paper
• Nonalcoholic Fatty Liver Disease Presenting With an Isolated Elevated Alkaline Phosphatase

  2006cited by this paper
• Hepatic steatosis in HIV–HCV coinfected patients: analysis of risk factors

  2006cited by this paper
• The Prevalence of Hepatitis C Virus Infection in the United States, 1999 through 2002

  2006cited by this paper
• HIV protease inhibitors activate the unfolded protein response and disrupt lipid metabolism in primary hepatocytes.

  2006cited by this paper
• Histological findings and clinical characteristics associated with hepatic steatosis in patients coinfected with HIV and hepatitis C virus.

  2005cited by this paper
• Outcome and prognostic markers in severe drug‐induced liver disease

  2005cited by this paper
• Hepatic steatosis and antiretroviral drug use among adults coinfected with HIV and hepatitis C virus

  2005cited by this paper
• Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year period.

  2005cited by this paper
• Influence of hepatitis C virus infection on HIV-1 disease progression and response to highly active antiretroviral therapy.

  2005cited by this paper
• Drug-induced hepatotoxicity: 2005.

  2005cited by this paper
• Contribution of metabolic factors to alanine aminotransferase activity in persons with other causes of liver disease.

  2005influential reference
• Hepatic steatosis in HIV/hepatitis C coinfection: Prevalence and significance compared with hepatitis C monoinfection

  2005cited by this paper
• Effect of antiretroviral drugs on liver fibrosis in HIV-infected patients with chronic hepatitis C: harmful impact of nevirapine

  2004cited by this paper
• Pitfalls of assessing hepatotoxicity in trials and observational cohorts.

  2004cited by this paper
• Lopinavir/ritonavir treatment in HIV antiretroviral‐experienced patients: evaluation of risk factors for liver enzyme elevation

  2004cited by this paper
• Longitudinal effect of antiretroviral therapy on markers of hepatic toxicity: impact of hepatitis C coinfection.

  2004cited by this paper
• Hepatotoxicity associated with protease inhibitor-based antiretroviral regimens with or without concurrent ritonavir

  2004cited by this paper
• HIV Infection, hepatitis C infection, and HAART: hard clinical choices.

  2004cited by this paper
• HIV infection and hepatic enzyme abnormalities: intricacies of the pathogenic mechanisms.

  2004cited by this paper
• Effects of HIV protease inhibitor therapy on lipid metabolism.

  2003cited by this paper
• Dyslipidemia in the era of HIV protease inhibitors.

  2003cited by this paper
• Severe Hepatotoxicity During Combination Antiretroviral Treatment: Incidence, Liver Histology, and Outcome

  2003cited by this paper
• Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values

  2003cited by this paper
• Factors participating in severe HCV-related liver disease in HIV/HCV co-infection

  2002cited by this paper
• Getting to the HAART of insulin resistance.

  2001cited by this paper
• Management of hepatitis C in HIV-infected persons.

  2001cited by this paper
• Factors affecting liver fibrosis in human immunodeficiency virus–and hepatitis C virus–coinfected patients: Impact of protease inhibitor therapy

  2001cited by this paper
• Survival after AIDS diagnosis in adolescents and adults during the treatment era, United States, 1984-1997.

  2001cited by this paper
• Hyperlipidemia and insulin resistance are induced by protease inhibitors independent of changes in body composition in patients with HIV infection.

  2000cited by this paper
• Effects of protease inhibitors on hyperglycemia, hyperlipidemia, and lipodystrophy: a 5-year cohort study.

  2000cited by this paper
• Health outcomes among patients treated by nurse practitioners or physicians.

  2000cited by this paper
• Pharmacology of nucleoside and nucleotide reverse transcriptase inhibitor-induced mitochondrial toxicity.

  2000cited by this paper
• Elevated liver enzymes following initiation of antiretroviral therapy

  2000cited by this paper
• Elevated liver enzymes following initiation of antiretroviral therapy.

  2000cited by this paper
• Hyperlipidemia and Insulin Resistance Are Induced by Protease Inhibitors Independent of Changes in Body Composition in Patients With HIV Infection

  2000cited by this paper
• HIV protease inhibitor-related lipodystrophy syndrome.

  2000cited by this paper
• Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: a cohort study.

  1999cited by this paper
• Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection.

  1998cited by this paper
• Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators.

  1998cited by this paper
• Gastric adenocarcinoma and kidney transplantation

  1998cited by this paper
• Drug-induced hepatotoxicity.

  1995cited by this paper
• Fatty liver hepatitis (steatohepatitis) and obesity: An autopsy study with analysis of risk factors

  1990cited by this paper

• Analysis of HIV therapy in the liver using optimal control and pharmacokinetics

  2025cites this paper
• HIV Infection and Antiretroviral Therapy Impair Liver Function in People Living with HIV: Systematic Review and Meta-Analysis

  2025cites this paper
• The clinical indexes and immunological status of HIV/AIDS patients undergoing different highly active antiretroviral treatments

  2024cites this paper
• SIV Infection Is Associated with Transient Acute-Phase Steatosis in Hepatocytes In Vivo

  2024cites this paper
• Alkaline Phosphatase: Biochemical And Clinical Aspects

  2024cites this paper
• Chronic Liver Enzyme Elevation and Use of Contemporary ARVs Among People With HIV

  2024cites this paper
• Aspartate Aminotransferase/Platelet Ratio Index Upon Admission Predicts 24-Week Mortality in Patients With HIV-Associated Talaromyces marneffei

  2023cites this paper
• Factors associated with high alanine aminotransferase (ALT) and cirrhosis in people living with HIV on combination antiretroviral treatment (cART) in the Asia‐Pacific

  2022cites this paper
• Changes in liver function test levels in HIV patients undergoing highly active antiretroviral therapy (HAART). Longitudinal study in Lima, Peru

  2022cites this paper
• Prevalence of hepatotoxicity among HIV-infected patients in Ethiopia: a systematic review and meta-analysis

  2022cites this paper
• Liver inflammation is common and linked to metabolic derangements in persons with treated HIV.

  2022cites this paper
• Risk factors of severe hepatotoxicity among HIV-1 infected individuals initiated on highly active antiretroviral therapy in the Northwest Region of Cameroon

  2022cites this paper
• Risk Factors Associated With Chronic Liver Enzyme Elevation in Persons With HIV Without Hepatitis B or C Coinfection in the Combination Antiretroviral Therapy Era

  2021cites this paper
• Substance Use, Highly Active Antiretroviral Therapy, and Liver Enzymes: Evidence From a Cross-Sectional Study of HIV-Infected Adult Patients Without Comorbidities on HAART in the University of Port Harcourt Teaching Hospital

  2021cites this paper
• Identification of hepatitis delta superinfection when investigating transaminitis in HIV/HBV coinfection.

  2021cites this paper
• Apoptosis of Hepatocytes: Relevance for HIV-Infected Patients under Treatment

  2021cites this paper
• Causative factors of liver fibrosis in HIV-infected patients. A single center study

  2020cites this paper
• Incidence of Hepatotoxicity in Iranian Patients With HIV on Antiretroviral Therapies and Its Correlation with Virologic Response to HIV Treatment.

  2020cites this paper
• Evaluation of the Liver Enzyme (AST, ALT & ALP) Levels of Adult HIV Patients on HAART in UPTH

  2020cites this paper
• Liver function tests and fibrosis scores in a rural population in Africa: a cross-sectional study to estimate the burden of disease and associated risk factors

  2020cites this paper
• Aetiology and severity of liver disease in HIV positive patients with suspected NAFLD: lessons from a cohort with available liver biopsies.

  2019cites this paper
• HEPATOBILIARY ABNORMALITIES AMONG PEOPLE LIVING WITH HIV/AIDS IN SOUTHERN ODISHA

  2019cites this paper
• Nonalcoholic fatty liver disease and hepatic fibrosis among perinatally HIV-monoinfected Asian adolescents receiving antiretroviral therapy

  2019cites this paper
• Alcohol Metabolism Potentiates HIV-Induced Hepatotoxicity: Contribution to End-Stage Liver Disease

  2019cites this paper
• Risk Factors for Alanine Aminotransferase Elevations in a Prospective Cohort of HIV-Infected Tanzanian Adults Initiating Antiretroviral Therapy

  2019cites this paper
• Liver function tests and fibrosis scores in a rural population in Africa: estimation of the burden of disease and associated risk factors

  2019cites this paper
• Antiretroviral Therpay Induced Liver Toxicity among Immunecompromised HIV Patients at Chu Brazzaville

  2019cites this paper
• Clinical significance of elevated liver transaminases in HIV-infected patients.

  2019influential citation
• Human immunodeficiency virus, elevated transaminases, fatty liver: the perfect storm?

  2019cites this paper
• Benefit of Early versus Deferred Antiretroviral Therapy on Progression of Liver Fibrosis among People with HIV in the START Randomized Trial

  2019cites this paper
• Aetiology and severity of liver disease in HIV positive patients with suspected NAFLD: Lessons from a cohort with available liver biopsies

  2018cites this paper
• Liver as a target of human immunodeficiency virus infection

  2018cites this paper
• CYTOKINES ASSOCIATED WITH ANTIRETROVIRAL INDUCED HEPATOTOXICITY IN PEOPLE INFECTED WITH THE HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 IN THE NORTHWEST REGION OF CAMEROON

  2018cites this paper
• Higher Levels of Cystatin C in HIV/AIDS Patients with Metabolic Syndrome

  2018cites this paper
• ADAR1 polymorphisms are related to severity of liver fibrosis in HIV/HCV-coinfected patients

  2017cites this paper
• HIV-1 viral protein R (Vpr) induces fatty liver in mice via LXRα and PPARα dysregulation: implications for HIV-specific pathogenesis of NAFLD

  2017cites this paper
• A cross-sectional study of liver function tests in HIV-infected persons in Western India.

  2017cites this paper
• Liver test abnormalities in patients with HIV mono-infection: assessment with simple noninvasive fibrosis markers

  2017cites this paper
• Metabolic syndrome and obesity are the cornerstones of liver fibrosis in HIV-monoinfected patients

  2017cites this paper
• Liver Function Tests Abnormalities and Hepatitis B Virus & Hepatitis C Virus Co-infection in Human Immunodeficiency Virus (HIV)-infected Patients in India.

  2017cites this paper
• Lifestyle and biological risk factors for liver fibrosis in the Miami Adult Studies on HIV (MASH) cohort: An HIV infected and HIV/HCV co-infected population

  2016cites this paper
• Antiretroviral Drugs and Risk of Chronic Alanine Aminotransferase Elevation in Human Immunodeficiency Virus (HIV)-Monoinfected Persons: The Data Collection on Adverse Events of Anti-HIV Drugs Study

  2016cites this paper
• Antiretroviral Treatment-Associated Hepatotoxicity and Anemia inPatients Receiving Stavudine or Zidovudine Containing Regimens in Sub-Saharan African Settings

  2016cites this paper
• Poorly Controlled HIV Infection: An Independent Risk Factor for Liver Fibrosis

  2016cites this paper
• Editorial Commentary: Elevated Aminotransferase Levels Among HIV-Infected Persons: What's Lurking Under the Surface?

  2015cites this paper
• THE EFFECT OF HAART ON LIVER DISEASE PROGRESSION IN HIV INFECTION

  2015cites this paper
• Occurrence of Painful Diabetic Peripheral Neuropathy among Type 2 Diabetic Patients Attending a Tertiary Care Hospital

  2015cites this paper
• Single Nucleotide Polymorphisms of CXCL9-11 Chemokines Are Associated With Liver Fibrosis in HIV/HCV-Coinfected Patients

  2015cites this paper
• Drug-induced liver injury in hospitalized HIV patients: high incidence and association with drugs for tuberculosis.

  2015cites this paper
• Association between IL7R polymorphisms and severe liver disease in HIV/HCV coinfected patients: a cross-sectional study

  2015cites this paper
• The effect of highly active antiretroviral therapy on liver function in human immunodeficiency virus-infected pediatric patients with or without hepatitis virus co-infection

  2015cites this paper
• Significance of liver enzymes as a baseline investigation in recently diagnosed HIV positive patients

  2015cites this paper
• Liver Function Abnormalities in Human Immunodeficiency Virus Positive Individuals and its Correlation with Disease Severity

  2015cites this paper
• Nonalcoholic Steatohepatitis and Hepatic Fibrosis in HIV-1-Monoinfected Adults With Elevated Aminotransferase Levels on Antiretroviral Therapy.

  2015cites this paper
• Association of Abnormal Liver Function Parameters with HIV Serostatus and CD4 Count in Antiretroviral-Naive Rwandan Women

  2015cites this paper
• Chronic liver disease in the human immunodeficiency virus patient.

  2015influential citation
• Evaluating Liver Disease in HIV-Infected Patients for the Primary Care Physician

  2014cites this paper
• Analysis of HIV Quasispecies Suggests Compartmentalization in the Liver

  2014cites this paper
• Common Lactation Problems: Impact of Lactation Management Clinic and Telephone Support in their Management - A 5-Year Prospective Study in Davangere South India

  2014cites this paper
• Serological survey of viral hepatitis markers among newly diagnosed patients with HIV/AIDS in China

  2013cites this paper
• Processes and participation in HIV and AIDS communication : using bodymapping to explore the experiences of young people.

  2013cites this paper
• Risk factors of chronic hepatitis in antiretroviral-treated HIV infection, without hepatitis B or C viral infection

  2013influential citation
• Elevated alanine aminotransferase in antiretroviral‐naïve HIV‐infected African patients: magnitude and risk factors

  2012cites this paper
• The association of HIV viral load with indirect markers of liver injury

  2012cites this paper
• High plasma CXCL10 levels are associated with HCV-genotype 1, and higher insulin resistance, fibrosis, and HIV viral load in HIV/HCV coinfected patients.

  2012influential citation
• HIV monoinfection is associated with increased aspartate aminotransferase-to-platelet ratio index, a surrogate marker for hepatic fibrosis.

  2012cites this paper
• Liver injury in HIV monoinfected patients: should we turn a blind eye to it?

  2012cites this paper
• Clinical implications of immune recovery during antiretroviral treatment for HIV infection

  2012cites this paper
• Chapter 38 – HIV Co-Infection Drug Toxicity

  2012cites this paper
• Low Prevalence of Chronic Hypertransaminasemia in a Cohort of HIV-Infected Patients with No Coinfections

  2012cites this paper
• Epidemiology of Liver Disease in Human Immunodeficiency Virus-Infected Persons

  2012cites this paper
• Influence of antiretroviral therapy on liver disease

  2011cites this paper
• Risk of Developing Specific Aids-Defining Illnesses and Opportunistic Infections in Romanian Coinfected Patients with HIv and Hepatitis B virus

  2011cites this paper
• Management of HIV-1 associated hepatitis in patients with acquired immunodeficiency syndrome: role of a successful control of viral replication

  2011cites this paper
• A Higher Correlation of HCV Core Antigen with CD4+ T Cell Counts Compared with HCV RNA in HCV/HIV-1 Coinfected Patients

  2011cites this paper
• Factors Associated with Elevated ALT in an International HIV/HBV Co-Infected Cohort on Long-Term HAART

  2011cites this paper
• Cryptogenic liver diseases: sailing by sight from HIV co-infection with hepatitis viruses to HIV mono-infection through the Pillars of Hercules.

  2011cites this paper
• HIV mono-infection is associated with FIB-4 - A noninvasive index of liver fibrosis - in women.

  2011cites this paper
• Prevalence and factors associated with liver test abnormalities among human immunodeficiency virus-infected persons.

  2010cites this paper
• Incidence and risk factors for chronic elevation of alanine aminotransferase levels in HIV-infected persons without hepatitis b or c virus co-infection.

  2010cites this paper
• Complicaciones no infecciosas en la infección por el VIH

  2010cites this paper
• Human immunodeficiency virus and liver disease: Conference proceedings

  2010cites this paper
• Uncommon hepatitis B virus and/or hepatitis C virus occult infection in HIV-positive patients with abnormal level of hepatic enzyme.

  2008cites this paper
• Nonalcoholic fatty liver disease in HIV-infected patients referred to a metabolic clinic: prevalence, characteristics, and predictors.

  2008cites this paper
• Low-dose, once-daily atazanavir/ritonavir (200/100): an effective treatment for HIV-infected patients in Thailand.

  2008cites this paper
• HIV and liver disease forum: Conference proceedings

  2007cites this paper
• Liver Disease in HIV-Infected Patients

  2007cites this paper
• Indian Association of Biomedical Scientists (iabms) Biomedicine General Information Publication Editorial Office Editorial Board International Advisory Council Editor-in-chief Language Editor Copy Right Communication Address Iii Former President of Iabms 004 Iv Review/special Articles 1. Chemical an

  year unknowncites this paper
• ASSOCIATION BETWEEN VIRAL INFECTIONS AND LIVER FUNCTION TESTS

  year unknowncites this paper